Clinical Trial

A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of HRS-8427 in patients with complicated urinary tract infection, including acute pyelonephritis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-22; most recent amendment 2025-01-21.
Status change: Not Yet Recruiting → Recruiting 2024-10-09
Trial Details
NCT Number NCT06569056
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)
Enrollment 578 participants
Start Date 2024-09-25
Primary Completion 2025-11 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-01-22